相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
Elena Tibaldi et al.
HAEMATOLOGICA (2017)
Structure-Activity Relationship of Curcumin: Role of the Methoxy Group in Anti-inflammatory and Anticolitis Effects of Curcumin
Haixia Yang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
Pablo Angulo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Syk inhibitors in clinical development for hematological malignancies
Delong Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Focal Adhesion Kinase as a Potential Target in AML and MDS
Bing Z. Carter et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Tyrosine Kinase Expressed in Hepatocellular Carcinoma, TEC, Controls Pluripotency and Early Cell Fate Decisions of Human Pluripotent Stem Cells via Regulation of Fibroblast Growth Factor-2 Secretion
Tereza Vanova et al.
STEM CELLS (2017)
Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
Elena Tibaldi et al.
HAEMATOLOGICA (2017)
Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection
G. Duwe et al.
EJSO (2017)
Bruton's tyrosine kinase (BTK) as a promising target in solid tumors
J. Molina-Cerrillo et al.
CANCER TREATMENT REVIEWS (2017)
Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats
Kalyani Chowdary Karnam et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine
Gahana Advani et al.
CELL COMMUNICATION AND SIGNALING (2017)
miR-24 represses metastasis of human osteosarcoma cells by targeting Acki via AKT/NIMPs pathway
Zhendong Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis
Julia E. Maxson et al.
CANCER RESEARCH (2016)
Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling
Aysun Adan et al.
TUMOR BIOLOGY (2016)
Interleukin-2-inducible T-cell kinase expression and relation to disease severity in systemic lupus erythematosus
Wang-Dong Xu et al.
CLINICA CHIMICA ACTA (2016)
Multifunctional Abl kinases in health and disease
Aaditya Khatri et al.
JOURNAL OF CELL SCIENCE (2016)
Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia
Yasmin Rosshandler et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms
Chaolan Lv et al.
MEDICAL SCIENCE MONITOR (2016)
Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation
Xin-pin Wu et al.
ACTA PHARMACOLOGICA SINICA (2015)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A
Francesca Zonta et al.
BLOOD (2015)
Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach
Atsushi Nonami et al.
BLOOD (2015)
JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
Lorraine Springuel et al.
HAEMATOLOGICA (2015)
ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling
Binhui Xie et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694
Yiming Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling
Song-Hui Xu et al.
JOURNAL OF PATHOLOGY (2015)
Src family kinases and their role in hematological malignancies
Matthew Ku et al.
LEUKEMIA & LYMPHOMA (2015)
Fyn is an important molecule in cancer pathogenesis and drug resistance
Daniel Elias et al.
PHARMACOLOGICAL RESEARCH (2015)
JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications
Lorraine Springuel et al.
HAEMATOLOGICA (2015)
Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway
X. Li et al.
ARCHIVES OF TOXICOLOGY (2015)
ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers
K. Mahajan et al.
ONCOGENE (2015)
The Emerging Role of ABL Kinases in Solid Tumors
Jun Wang et al.
TRENDS IN CANCER (2015)
High expression of GTPase regulator associated with the focal adhesion kinase (GRAF) is a favorable prognostic factor in acute myeloid leukemia
Rabab M. Aly et al.
BLOOD CELLS MOLECULES AND DISEASES (2014)
Molecular Pathways: Targeting the Microenvironment in Chronic Lymphocytic Leukemia-Focus on the B-Cell Receptor
Elisa ten Hacken et al.
CLINICAL CANCER RESEARCH (2014)
Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation
Xianping Shi et al.
CLINICAL CANCER RESEARCH (2014)
Ibrutinib and Indolent B-Cell Lymphomas
Akintunde Akinleye et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2014)
An overview of FDA-approved new molecular entities: 1827-2013
Michael S. Kinch et al.
DRUG DISCOVERY TODAY (2014)
Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia
Cristina Gattazzo et al.
HAEMATOLOGICA (2014)
Acute Myeloid Leukemia with BCR/ABL Fusion Chimera
Manoj Madashira Gopal et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2014)
Homoharringtonine and omacetaxine for myeloid hematological malignancies
Shuqing Lu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Importance of microbial natural products and the need to revitalize their discovery
Arnold L. Demain
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2014)
Induction of human chronic myeloid leukemia K562 cell apoptosis by virosecurinine and its molecular mechanism
Gang Zhang et al.
MOLECULAR MEDICINE REPORTS (2014)
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
A. Bouchekioua et al.
LEUKEMIA (2014)
Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia
Gege Feng et al.
LEUKEMIA & LYMPHOMA (2014)
Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells
Soner Solmaz et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2014)
The SH2 domain of Abl kinases regulates kinase autophosphorylation by controlling activation loop accessibility
Allan Joaquim Lamontanara et al.
NATURE COMMUNICATIONS (2014)
Current understanding of tyrosine kinase BMX in inflammation and its inhibitors
Le Qiu et al.
BURNS & TRAUMA (2014)
Nephrotoxicity of recent anti-cancer agents
Norbert Lameire
CLINICAL KIDNEY JOURNAL (2014)
Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug- resistant K562/ADM tumors in mice
G. Y. Li et al.
ADVANCES IN MEDICAL SCIENCES (2013)
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors
J. Cortes et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
ACK1 tyrosine kinase: Targeted inhibition to block cancer cell proliferation
Kiran Mahajan et al.
CANCER LETTERS (2013)
Inhibition of SRC Corrects GM-CSF Hypersensitivity That Underlies Juvenile Myelomonocytic Leukemia
Severa Bunda et al.
CANCER RESEARCH (2013)
A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome
N. Daver et al.
EUROPEAN JOURNAL OF CANCER CARE (2013)
Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors
Franck E. Nicolini et al.
HAEMATOLOGICA (2013)
Structure and Dynamic Regulation of Abl Kinases
Shoghag Panjarian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias
Bernard Bourrie et al.
LEUKEMIA & LYMPHOMA (2013)
Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia
Hirotoshi Sakaguchi et al.
NATURE GENETICS (2013)
JAK/STAT signaling in hematological malignancies
W. Vainchenker et al.
ONCOGENE (2013)
TYK2-STAT1-BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia
Takaomi Sanda et al.
CANCER DISCOVERY (2013)
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
Muhammad Furqan et al.
BIOMARKER RESEARCH (2013)
Role of ABL family kinases in cancer: from leukaemia to solid tumours
Emileigh K. Greuber et al.
NATURE REVIEWS CANCER (2013)
Gambogic acid activates AMP-activated protein kinase in mammalian cells
Baobing Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers
Nancy L. Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
Jorge Cortes et al.
BLOOD (2012)
Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation
Marie-Magdelaine Coude et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Oridonin in combination with imatinib exerts synergetic anti-leukemia effects in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway
Yong Guo et al.
CANCER BIOLOGY & THERAPY (2012)
p120RasGAP-Mediated Activation of c-Src Is Critical for Oncogenic Ras to Induce Tumor Invasion
Po-Chao Chan et al.
CANCER RESEARCH (2012)
Small-Molecule Inhibitors of the c-Fes Protein-Tyrosine Kinase
Sabine Hellwig et al.
CHEMISTRY & BIOLOGY (2012)
Studies on gambogic acid (IV): Exploring structure-activity relationship with IκB kinase-beta (IKKβ)
Haopeng Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Regulation of the Src Family Kinases by Csk
Masato Okada
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
The Role of the Tec Kinase Bruton's Tyrosine Kinase (Btk) in Leukocyte Recruitment
Helena Block et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)
Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis
Xiao-hua Xu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2012)
Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells
Sangkil Nam et al.
MOLECULAR ONCOLOGY (2012)
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
J. Congleton et al.
LEUKEMIA (2012)
Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia
T. Bains et al.
LEUKEMIA (2012)
Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms
Zhao-Li Zhou et al.
NATURAL PRODUCT REPORTS (2012)
BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
Oliver Hantschel et al.
NATURE CHEMICAL BIOLOGY (2012)
Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia
Melissa M. Singh et al.
PLOS ONE (2012)
Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
Siyuan Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Focal adhesion kinase is a phospho-regulated repressor of Rac and proliferation in human endothelial cells
Patrick W. Bryant et al.
BIOLOGY OPEN (2012)
Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
F. Condorelli et al.
CURRENT MEDICINAL CHEMISTRY (2011)
The Syk kinase as a therapeutic target in leukemia and lymphoma
Dimitar G. Efremov et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
The Tyrosine Kinase BMX Is an Essential Mediator of Inflammatory Arthritis in a Kinase-Independent Manner
Marie Gottar-Guillier et al.
JOURNAL OF IMMUNOLOGY (2011)
High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells
Meredith C. Henderson et al.
MOLECULAR CANCER RESEARCH (2011)
Focal adhesion kinase as a target in the treatment of hematological malignancies
Bu Yin
LEUKEMIA RESEARCH (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Systems biology of JAK-STAT signalling in human malignancies
Julio Vera et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2011)
Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
David DeRemer et al.
Cancer Management and Research (2011)
GENT: Gene Expression Database of Normal and Tumor Tissues
Gwangsik Shin et al.
CANCER INFORMATICS (2011)
Tyrosine kinase inhibitors in hematological malignancies
Kamila Kosior et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2011)
ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon
Tekla Hornakova et al.
BLOOD (2010)
Polymorphisms in the multidrug resistance gene MDR1 (ABCB1) predict for molecular resistance in patients with newly diagnosed chronic myeloid leukemia receiving high-dose imatinib
Wendy Deenik et al.
BLOOD (2010)
Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation
Zhongzheng Lu et al.
CANCER LETTERS (2010)
Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
Erica L. Mayer et al.
CLINICAL CANCER RESEARCH (2010)
The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge
Franck E. Nicolini et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
An oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in vitro
Rong Mu et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Expression of a Src Family Kinase in Chronic Myelogenous Leukemia Cells Induces Resistance to Imatinib in a Kinase-dependent Manner
Teodora Pene-Dumitrescu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Shepherding AKT and Androgen Receptor by Ack1 Tyrosine Kinase
Kiran Mahajan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl
Zhongzheng Lu et al.
MOLECULAR CANCER (2010)
FES kinases are required for oncogenic FLT3 signaling
E. Voisset et al.
LEUKEMIA (2010)
Kinase mutations in human disease: interpreting genotype-phenotype relationships
Piya Lahiry et al.
NATURE REVIEWS GENETICS (2010)
Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation
Kiran Mahajan et al.
PLOS ONE (2010)
ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
John Colicelli
SCIENCE SIGNALING (2010)
Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
Stella Chai et al.
Chinese Medicine (2010)
The SYK tyrosine kinase: a crucial player in diverse biological functions
Attila Mocsai et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo
Yan-lin Wei et al.
ACTA PHARMACOLOGICA SINICA (2009)
The Antiproliferation Effect of Berbamine on K562 Resistant Cells by Inhibiting NF-κB Pathway
Yan-Lin Wei et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2009)
Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies
Kais Hussein et al.
ANNALS OF HEMATOLOGY (2009)
Syk and pTyr'd: Signaling through the B cell antigen receptor
Robert L. Geahlen
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804
Richard M. Stone et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation
Xianping Shi et al.
CLINICAL CANCER RESEARCH (2009)
Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: A pilot randomized and placebo-controlled clinical trial
Guang-Yao Li et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2009)
NF-κB regulates the transcription of protein tyrosine kinase Tec
Liang Yu et al.
FEBS JOURNAL (2009)
Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
Abdalla J. Mohamed et al.
IMMUNOLOGICAL REVIEWS (2009)
Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk
Julie A. Readinger et al.
IMMUNOLOGICAL REVIEWS (2009)
Effect of Haishengsu as an Adjunct Therapy for Patients with Advanced Renal Cell Cancer: A Randomized and Placebo-Controlled Clinical Trial
Ji-Zhu Liu et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2009)
Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells
Yin Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mechanisms of Gambogic Acid-Induced Apoptosis in Non-Small Cell Lung Cancer Cells in Relation to Transferrin Receptors
Xiaoli Zhu et al.
JOURNAL OF CHEMOTHERAPY (2009)
Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice
Y. Chen et al.
LEUKEMIA (2009)
The effect of homoharringtonine in patients with chronic myeloid leukemia who have failed or responded suboptimally to imatinib therapy
Yu-Feng Li et al.
LEUKEMIA & LYMPHOMA (2009)
Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues
Sermin Ozkal et al.
PATHOLOGY RESEARCH AND PRACTICE (2009)
JAK mutations in high-risk childhood acute lymphoblastic leukemia
Charles G. Mullighan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources
Chunlei Wu et al.
GENOME BIOLOGY (2009)
Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells
Audrey Sirvent et al.
BIOLOGY OF THE CELL (2008)
Identification of somatic JAK1 mutations in patients with acute myeloid leukemia
Zhifu Xiang et al.
BLOOD (2008)
GLOBAL HEALTH Health care reform in Chile
Gabriel Bastias et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers
Eun Goo Jeong et al.
CLINICAL CANCER RESEARCH (2008)
Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells
Hongyan Tong et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Dysregulation of Ack1 inhibits down-regulation of the EGF receptor
Lene Melsoether Grovdal et al.
EXPERIMENTAL CELL RESEARCH (2008)
Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia
Basem M. William et al.
HEMATOLOGY (2008)
A crucial role in cell spreading for the interaction of Abl PxxP motifs with Crk and Nck adaptors
Susumu Antoku et al.
JOURNAL OF CELL SCIENCE (2008)
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
Elisabetta Flex et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival
Martin Felices et al.
JOURNAL OF IMMUNOLOGY (2008)
Tyrosine Phosphorylation in the SH3 Domain Disrupts Negative Regulatory Interactions within the c-Abl Kinase Core
Shugui Chen et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
JAK and MPL mutations in myeloid malignancies
Ayalew Tefferi
LEUKEMIA & LYMPHOMA (2008)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Georg Lenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The JAK kinases: Not just another kinase drug discovery target
Andrew F. Wilks
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Mining for JAK-STAT mutations in cancer
Stefan N. Constantinescu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
The tyrosine kinase FES is an essential effector of KITD816V proliferation signal
Edwige Voisset et al.
BLOOD (2007)
Thirty-eight-negative kinase 1 (TNK1) facilitates TNFα-induced apoptosis by blocking NF-κB activation
N. Azoitei et al.
ONCOGENE (2007)
Signal transduction pathways that contribute to myeloid differentiation
M. B. Miranda et al.
LEUKEMIA (2007)
Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study
Arghya Ray et al.
BLOOD (2007)
Philadelphia chromosome-positive acute myeloid leukemia - A rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis
Chad P. Soupir et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy
Alfonso Quintas-Cardama et al.
CANCER (2007)
JAK-2 mutations and their relevance to myeloproliferative disease
Ross L. Levine et al.
CURRENT OPINION IN HEMATOLOGY (2007)
Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity
Malcolm A. Meyn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinases
Andrew Chase et al.
CLINICAL SCIENCE (2006)
Frequent alterations in the expression of serine/threonine kinases in human cancers
Maria Capra et al.
CANCER RESEARCH (2006)
Activating alleles of JAK3 in acute megakaryoblastic leukemia
Denise K. Walters et al.
CANCER CELL (2006)
JAW/STAT signal transduction: Regulators and implication in hematological malignancies
L Valentino et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Role of tyrosine kinase inhibitors in cancer therapy
A Arora et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: Role of Ack1 in polyubiquitination of tumor suppressor Wwox.
NP Mahajan et al.
CANCER RESEARCH (2005)
Tec kinases regulate TCR-mediated recruitment of signaling molecules and integrin-dependent cell adhesion
LD Finkelstein et al.
JOURNAL OF IMMUNOLOGY (2005)
An identity crisis for fps/fes:: Oncogene or tumor suppressor?
W Sangrar et al.
CANCER RESEARCH (2005)
Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib
D Marin et al.
CANCER (2005)
Ubiquitination and degradation of the Arg tyrosine kinase is regulated by oxidative stress
C Cao et al.
ONCOGENE (2005)
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematofogic malignancies
M Wadleigh et al.
BLOOD (2005)
Denbinobin-mediated anticancer effect in human K562 leukemia cells: role in tubulin polymerization and Bcr-Abl activity
YC Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate
T Illmer et al.
LEUKEMIA (2004)
Mitochondrial dysfunction as an early event in the process of apoptosis induced by woodfordin I in human leukemia K562 cells
MJ Liu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Structure and regulation of Src family kinases
TJ Boggon et al.
ONCOGENE (2004)
The interplay between Src family kinases and receptor tyrosine kinases
PA Bromann et al.
ONCOGENE (2004)
Src-family kinases in B-cell development and signaling
SB Gauld et al.
ONCOGENE (2004)
Not so strange bedfellows: G-protein-coupled receptors and Src family kinases
DK Luttrell et al.
ONCOGENE (2004)
Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation
EH Palacios et al.
ONCOGENE (2004)
Src family kinases, key regulators of signal transduction
SJ Parsons et al.
ONCOGENE (2004)
The interplay between Src and integrins in normal and tumor biology
MP Playford et al.
ONCOGENE (2004)
Emerging roles for p120-catenin in cell adhesion and cancer
AB Reynolds et al.
ONCOGENE (2004)
Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis
CM Silva
ONCOGENE (2004)
Chlorogenic acid-inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells
G Bandyopadhyay et al.
BLOOD (2004)
Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis
C Recher et al.
CANCER RESEARCH (2004)
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin
KI Priyadarsini et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase
S O'Brien et al.
CANCER (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Kos1, a nonreceptor tyrosine kinase that suppresses Ras signaling
K Hoare et al.
ONCOGENE (2003)
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571
NJ Donato et al.
BLOOD (2003)
Src family kinases in tumor progression and metastasis
JM Summy et al.
CANCER AND METASTASIS REVIEWS (2003)
Src family kinases: Potential targets for the treatment of human cancer and leukemia
M Warmuth et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
Identification of Src transformation fingerprint in human colon cancer
RL Malek et al.
ONCOGENE (2002)
Regulation and targets of receptor tyrosine kinases
T Pawson
EUROPEAN JOURNAL OF CANCER (2002)
Bcr-Abl variants:: biological and clinical aspects
AS Advani et al.
LEUKEMIA RESEARCH (2002)
In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells
B Scappini et al.
CANCER (2002)
Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease
B Scheijen et al.
ONCOGENE (2002)
Simultaneous homoharringtonine and interferon-α in the treatment of patients with chronic-phase chronic myelogenous leukemia
S O'Brien et al.
CANCER (2002)
Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcription
Y Takeba et al.
JOURNAL OF IMMUNOLOGY (2002)
Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction
C Haan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents
Y Kano et al.
BLOOD (2001)
Development of inhibitors for protein tyrosine kinases
FA Al-Obeidi et al.
ONCOGENE (2000)
Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia
HM Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
